Luc-André Granier
Chairman en Averoa SAS .
Perfil
Luc-André Granier founded Advicenne SA in 2007, where he worked as Chief Executive Officer from 2007 to 2011.
Dr. Granier also currently works at Averoa SAS, as Chairman, American Society of Nephrology, as Member, Société Française d'Etude et de Traitement de la Douleur, as Member, International League Against Epilepsy, as Member, and International Pediatric Nephrology Association, as Member.
Dr. Granier also formerly worked at Theranexus SA, as Independent Director from 2017 to 2020, Eli Lilly & Co., as Senior Clinical Research Physician, Synt:em SA, as Vice President-Clinical Research, International Association for the Study of Pain, as Member, and FORENAP Pharma SARL, as Head-Clinical Research Unit.
Dr. Granier received his doctorate degree from the University of Strasbourg.
Cargos activos de Luc-André Granier
Empresas | Cargo | Inicio |
---|---|---|
Société Française d'Etude et de Traitement de la Douleur | Corporate Officer/Principal | - |
International League Against Epilepsy | Corporate Officer/Principal | - |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
International Pediatric Nephrology Association | Corporate Officer/Principal | - |
Averoa SAS
Averoa SAS Miscellaneous Commercial ServicesCommercial Services Averoa SAS is a French biotechnology company founded in 2021. The private company is based in Grenoble, France and engages in research and development in biotechnology. | Chairman | - |
Antiguos cargos conocidos de Luc-André Granier.
Empresas | Cargo | Fin |
---|---|---|
ADVICENNE | Chief Executive Officer | 13/03/2020 |
THERANEXUS | Chairman | - |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Corporate Officer/Principal | - |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Corporate Officer/Principal | - |
░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Luc-André Granier.
University of Strasbourg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ADVICENNE | Health Technology |
THERANEXUS | Health Technology |
Empresas privadas | 8 |
---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
American Society of Nephrology
American Society of Nephrology Medical/Nursing ServicesHealth Services American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC. | Health Services |
International Association for the Study of Pain
International Association for the Study of Pain Miscellaneous Commercial ServicesCommercial Services International Association for the Study of Pain operates as a professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain. The company was founded in 1973 and is headquartered in Washington, DC. | Commercial Services |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Commercial Services |
Société Française d'Etude et de Traitement de la Douleur | |
International League Against Epilepsy | |
International Pediatric Nephrology Association | |
Averoa SAS
Averoa SAS Miscellaneous Commercial ServicesCommercial Services Averoa SAS is a French biotechnology company founded in 2021. The private company is based in Grenoble, France and engages in research and development in biotechnology. | Commercial Services |
- Bolsa de valores
- Insiders
- Luc-André Granier